Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 75%
filed 2026-06-11
Item 5.02
The filing discloses both the retirement of Russell R. Shaller as President and CEO and the appointment of Vineet Nargolwala as President and CEO, effective June 8, 2026. While both events are disclosed, the principal action emphasized is Nargolwala's appointment to the top executive role, supported by detailed compensation terms ($1M base salary, $6.4M annual stock award, severance provisions, and change-of-control protections). The appointment of a new CEO is material to investors and represents the primary disclosed event, though the departure of the prior CEO is also significant.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
The filing discloses the appointment of Matthew Bradford White as Chief Legal Officer effective June 8, 2026. While the section also details compensatory arrangements (base salary of $500,000, performance bonus, RSUs, signing bonus, and retention bonus), the principal disclosed action is the appointment of a named executive officer to a material position. The compensation details are ancillary to the appointment itself.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-11
Item 5.02
Steven Day was appointed as interim Chief Financial Officer of Adobe effective immediately, following the resignation of Daniel Durn as CFO effective June 15, 2026. Day has been with the company since 2006 and brings substantial prior experience in financial leadership roles.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-06-11
Item 5.02
The Board appointed John C. Fortson as Executive Vice President & Chief Financial Officer, effective July 20, 2026, with a base salary of $780,000, target bonus of 85%, sign-on payments, and equity awards. This represents a material change in senior leadership responsible for financial management and reporting.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
Kenneth Escoe was elected to the Board of Directors of Ingredion Inc. effective July 1, 2026. This is a director appointment disclosed under Item 5.02(d). While the disclosure includes standard compensation details for non-management directors (cash retainer and restricted stock units), the principal action is the appointment of a new director, making exec_appointment the most salient classification. Board composition changes are material to investors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-11
Item 5.02
Aaron Schutt was appointed Chief Executive Officer of Alaska Silver Corp. effective October 1, 2026, with a comprehensive employment agreement including base salary of $300,000, bonus structure up to 70% of base, 500,000 stock options, and severance provisions. Christopher Marrs departed as President and CEO in connection with this transition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
Paul F. De Cock was appointed Chief Executive Officer and Director of Mohawk Industries, effective September 30, 2026, succeeding retiring CEO Jeffrey S. Lorberbaum. The appointment includes a base salary of $1,267,000, bonus structure, and an equity award of 30,000 RSUs, representing a material executive transition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
The filing discloses the election of Tiffany To as a member of the Board of Directors on June 5, 2026. While the disclosure includes compensation details (annual base retainer of $107,500 and a one-time equity grant of $177,500 in restricted stock units), the principal action is the appointment of a new director to the Board. This is a material event affecting the composition of the company's governance and is appropriately classified as an executive appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 8.01
Mohamed Genead, M.D., M.Sc., was appointed as Chief Medical Officer of Ocugen effective June 11, 2026, following his service as Acting/Interim Chief Medical Officer since May 8, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 93%
filed 2026-06-11
Item 5.02
Ms. Jehna Silva was appointed as a director of Farmers & Merchants Bancorp effective June 8, 2026, and assigned to three board committees (CRA, Budget and Finance, and ALCO). The appointment is material due to its impact on board composition and governance structure, and notably involves a family relationship with CEO Kent Steinwert that is relevant to investors assessing board independence.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-11
Item 5.02
The filing discloses the appointment of Kevin J. Necas, Jr. as Senior Vice President – Chief Accounting Officer and principal accounting officer effective July 2, 2026. While Michael P. Gallagher's retirement is also mentioned, the principal disclosed action centers on the appointment of Necas to a key financial officer role. The appointment of a principal accounting officer is material to investors as it affects the registrant's financial reporting oversight and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-11
Item 5.02
Daniel Durn was appointed as Chief Financial Officer and Executive Vice President of Marvell Technology effective June 15, 2026, with a compensation package including $850,000 base salary, $1,000,000 sign-on bonus, and approximately 103,508 RSUs in equity grants.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
The Board approved the appointment of Yiftach Kleinman as Chief Executive Officer, effective no later than September 8, 2026, with a base salary of NIS 80,000/month, bonus structure, and an equity grant of 53,600 options. Mr. Balucka was relieved from the CEO role as part of this leadership transition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-11
Item 5.02
Matt Davidson, Ph.D. was appointed as Chief Development Officer and Class I Director, and Wendy B. Young, Ph.D. was appointed as Class III Director, both effective immediately upon closing of the Azora merger on June 11, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
The filing discloses the appointment of Roy Cohen as Chief Financial Officer, effective June 1, 2026. The principal action is a person taking a role—a named executive officer position. While compensation terms are disclosed (NIS 55,000–65,000 per month), the core event is the appointment itself, not a compensation arrangement. CFO appointments are material to investors as they affect financial reporting oversight and corporate governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
The filing discloses the appointment of Mr. Theocharis Vasilakis as Chief Technology Officer of Elvictor Group, Inc., effective June 11, 2026, with direct reporting to the CEO and responsibility for technology strategy, digital transformation, AI/ML infrastructure, and software engineering operations. This is a material executive appointment under Item 5.02, as the CTO role is a senior officer position with significant operational responsibilities.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
Keith Wyness and Robert Warfield were appointed to the board of directors effective June 9, 2026, and Grinberg, Wyness, and Warfield were appointed to three board committees (Audit, Compensation, and Corporate Governance and Nominating) with specified chair roles in connection with the company's IPO.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-11
Item 5.02
Following the change of control, new executive leadership was appointed effective June 5, 2026: Elmurod Sopiev as CEO, Temur Zokirov as Chairman/CFO/Secretary, and two independent directors (Bahtiyor Kadirov and Elina Davidyan). Three prior executives (Viktor Balan, Alarcon Martinez Marcelo Ramon, and Anna Toczko) resigned in connection with the transaction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-11
Item 5.02
Zach Sawtelle was appointed Chief Operating Officer effective June 10, 2026, and designated Chief Executive Officer effective January 1, 2027, succeeding retiring CEO Elias J. Sabo. This executive succession is material to investors' assessment of the company's leadership and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-11
Item 5.02
The filing discloses both a director resignation (Irwin Katsof) and a director appointment (William Conkling). While both events are present, the substantive focus and detail center on the appointment of Conkling, including his extensive background in pharmaceutical commercialization, his independence determination, and his committee assignments (Audit Committee Chair and Financial Expert). The resignation is noted as non-contentious and receives minimal disclosure. Director appointments are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-11
Item 5.02
The filing discloses multiple executive appointments on June 9, 2026: Zhao Ling as CEO, Yang Fuzhu as Chairman, Zhang Wenmin as CFO, and four independent directors. While two departures also occurred (Chen Yuanhang as CEO and Wei Zurui as CFO/director), the dominant narrative and bulk of disclosure focuses on the new appointments with detailed biographical information for each appointee. This is a material leadership transition affecting the company's governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-11
The filing's primary substantive disclosure under Item 5.02 is the appointment of Jordan Zwick to the Board of Directors on June 10, 2026, expanding the Board from five to six directors. While the filing also covers shareholder vote results (Item 5.07) and equity plan amendments, the appointment of a new director with Audit Committee assignment is the most salient executive personnel action disclosed and would be material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-11
Item 5.02
Eric Park was appointed Chief Accounting Officer effective June 8, 2026, assuming the role of principal accounting officer. While the disclosure also includes compensatory arrangements (base salary increase to $300,000, bonus target of $200,000, and a $175,000 PRSU award), the principal disclosed action is the appointment itself. The appointment of a principal accounting officer is material to investors as it affects the registrant's financial reporting oversight and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-11
Item 5.02
The Board appointed three new independent directors—Robert Fotheringham, Zhenlong Jiao, and Henoc Muamba—on June 9, 2026, expanding the Board from three to six members. The new directors were assigned to lead key committees (Audit, Compensation, and Nominating and Corporate Governance), materially strengthening the company's governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-11
Item 5.02
The filing discloses the appointment of two new officers effective June 1, 2026: Andrew MacLeod as Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) and Robert Givens as Secretary. While the section also includes Michael Ssebugwawo's resignation from CFO and other officer roles, the principal disclosed action centers on filling those critical positions with new appointees. The appointments of a CFO and Secretary are material to investors' assessment of the company's governance and financial reporting structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 7.01
The filing discloses the appointment of Ms. Craig to the Board of Directors via press release issued on June 11, 2026. Board appointments are material events affecting the composition and governance of the registrant and would inform a reasonable investor's assessment of the company's leadership and oversight structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-10
Item 5.02
Colin M. Adams was elected as a director of Sleep Number's Board effective immediately on June 4, 2026, increasing the Board to 7 members with 6 independent directors. This is a clear executive appointment event. While the disclosure also mentions his compensation arrangement ($40,000 monthly fee), the principal action disclosed is the appointment itself, not a compensation arrangement modification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 90%
filed 2026-06-10
Item 5.02
Joseph Billante was elected and appointed as Chief Financial Officer effective July 27, 2026, succeeding retiring CFO Jay D. Martin. The disclosure includes Billante's background and compensation package as part of the appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-10
Item 5.02
The filing discloses the Board's appointment of Anthony Vang as the Company's full-time Chief Financial Officer effective June 5, 2026. Although Mr. Vang has performed CFO duties since inception, the formal appointment to the CFO title is the principal disclosed action. This is material as it represents a formal governance change and clarifies the CFO role structure ahead of the Company's Nasdaq uplisting application.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-10
Item 5.02
Mark A. Talley was appointed as an Independent Trustee to fill a vacancy on the Board, with assignment to three committees. Jeffrey P. Somers resigned from the Board, but the filing's principal focus is on Talley's election and his qualifications and committee assignments.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-10
Item 5.02
The Board elected Elena B. Poptodorova as an Independent Trustee on June 9, 2026, increasing the Board size from seven to eight members and assigning her to the Audit, Compensation, and Nominating and Governance committees.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-10
Item 5.02
Seven directors (Siyu Huang, Alex Yu, Joseph Taylor, Uwe Keller, Liad Meidar, Dieter Zetsche, and Jon Nelson) were appointed to the PubCo Board, and four named executive officers were appointed effective immediately following the merger: Siyu Huang as CEO, Richard Wei as CFO, Alex Yu as CTO, and Jason Duva as General Counsel and Secretary.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-10
Item 5.02
John Gehre was appointed as Chairman of the Board effective June 9, 2026. The appointment represents a material change to the company's governance and leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-10
Item 5.02
Elizabeth S. Perkins, the Company's Senior Vice President and Chief Financial Officer, was appointed to the additional role of principal accounting officer on June 10, 2026, succeeding Rachel Labrecque who passed away on June 9, 2026. While the disclosure involves a departure (Labrecque's death), the principal disclosed action is Perkins' appointment to a key accounting role, making exec_appointment the most salient classification. The appointment of a principal accounting officer is material to investors as it affects financial reporting oversight and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-10
Item 5.02
The filing discloses the appointment of Ma. Fatima D. Francisco to the Board of Directors as a Class I director, effective June 15, 2026. While the disclosure also includes compensatory arrangements (annual retainer of $50,000 and an option grant of 85,937 shares), the principal action is the appointment itself. The appointment of a new director is material to investors as it affects board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-10
Item 5.02
WhiteHawk Minerals appointed four key officers effective upon closing of the offering: Daniel Herz as CEO and President, Jeffrey Slotterback as CFO/Treasurer/Secretary, Stephen Pilatzke as Chief Accounting Officer, and Michael Downs as COO. These material C-suite appointments reflect the company's transition to internal management in connection with its public offering.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-10
Item 5.02
The filing discloses the appointment of Erik Blum as President effective June 1, 2026, with a detailed employment agreement specifying $200,000 base salary, $50,000 restricted stock grant, and up to 20% performance bonus. While the section also mentions Patricia Kaelin's dismissal as CFO, the primary focus and substantive disclosure centers on Blum's appointment and compensatory arrangements. This is material as it represents a significant executive appointment with detailed compensation terms affecting the company's leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-10
Item 5.02
The disclosure centers on the Board's approval and appointment of Todd Diganci as a director effective August 1, 2026, expanding the Board from nine to ten members. While the section also mentions standard director compensation arrangements, the principal disclosed action is the appointment of a new director with significant financial and regulatory experience (former FINRA EVP/CFO/CAO), making this an exec_appointment event. The appointment is material as it affects Board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-10
Item 7.01
The filing discloses the appointment of Dr. Clemens as Chief Financial Officer, announced via press release on June 10, 2026. This is a material executive appointment to a named officer position (CFO), which would affect a reasonable investor's assessment of the company's leadership and financial oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-10
The filing discloses the appointment of Eric B. Colby as Executive Vice President, Corporate Development and Investor Relations, effective June 8, 2026, along with a detailed employment agreement specifying compensation ($450,000 base salary plus 80% target bonus), severance provisions, and change-of-control protections. While the agreement also contains compensatory terms, the principal disclosed action is Colby's appointment to an executive officer role at a mining company, making this an exec_appointment event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-10
Item 7.01
The disclosure centers on Aaron Rankin, a founder and board member, assuming the role of Chief Technology Officer effective August 3, 2026. While Alan Boyce's resignation is also mentioned, the principal action disclosed is Rankin's appointment to the CTO position, making this an executive appointment event. The CTO role is material to a technology-driven company like Sprout Social, and the appointment of a founder to this position would affect investor assessment of the company's technical leadership and strategy.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-10
Item 5.02
Donald E. Simmons was appointed as Executive Vice President and Chief Operating Officer effective July 1, 2026, a significant promotion to a C-suite role with a base salary of $950,000 and equity awards totaling $4.7 million.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-10
Item 5.02
UFP Technologies appointed Mitchell C. Rock as Chief Executive Officer and Board member, and Ryan Stafford as General Counsel, Senior Vice President of Human Resources, and Secretary, effective June 4, 2026. These appointments represent material changes to the company's executive leadership and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-10
Item 5.02
The disclosure centers on the Board's approval of Timothy Coughlin's appointment as a Class III director effective immediately, along with his appointment as Chair of the Audit Committee. While the filing also mentions standard non-employee director compensation arrangements, the principal disclosed action is the appointment of a new director and committee chair, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-10
Item 5.02
The filing discloses the appointment of Sarah Jewett as Chief Operating Officer, effective June 15, 2026. While the disclosure includes compensatory details (base salary of $400,000, performance bonus target of 55%, and 29,629 RSUs), the principal action is the appointment of a named executive to a C-suite officer role. This is material to investors as it affects the Company's leadership structure and operational direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-10
Item 5.02
EquipmentShare.com Inc appointed two new directors, Damian Giangiacomo and Harley Miller, to the Board effective June 8, 2026, following the resignations of two other directors. The new directors bring relevant qualifications and have been assigned to board committees with compensation of $250,000 each.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-09
Item 5.02
Dr. Michael Philip Kimel was appointed as Chief Financial Officer effective June 9, 2026, with a base salary of $350,000 and a pending equity award. Steven Perez was simultaneously appointed as an independent director with $120,000 annual cash compensation. These appointments represent material changes to the registrant's executive and board leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-09
Item 7.01
Paul Miller was appointed Executive Vice President, Chief Purchasing and Merchandising Officer, effective June 9, 2026, bringing 25 years of tenure with the company in progressively senior roles. This appointment fills a critical C-suite position overseeing merchandising and purchasing functions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-09
Item 5.02
The filing discloses the appointment of Alexis Black Björlin as a member of the Board of Directors on June 9, 2026. While the section also mentions her compensation arrangement under the 2025 Director Compensation Plan, the principal disclosed action is her appointment to the Board and assignment to the Governance and Sustainability Committee. Board appointments are material events affecting corporate governance and investor assessment of the company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-09
Item 5.02
The filing discloses the appointment of Donna T. Guerra to the Board of Directors of Fifth District Bancorp, Inc. and its bank subsidiary effective June 8, 2026. The principal action is a person taking a director role, with detailed background information provided on her qualifications, including prior CFO and COO experience at Hibernia Bank. Board appointments are material events affecting corporate governance and investor assessment of the company.
View raw filing on EDGAR →